Multiple steps are involved in the pathogenesis of chronic lymphocytic leukemia (CLL) and various factors are related to its development: cytogenetic aberrations, antigenic triggers activated by ...

Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in Western countries. It is characterized by the progressive accumulation of mature-appearing yet immunologically dysfunctional B ...

Chronic myeloid leukemia (CML) The word "myeloid" also refers to a group of cells that differentiate, or mature, from a common myeloid progenitor cell type. The myeloid term also includes these ...

Tafasitamab (MOR-208, XmAb5574) is under development for the treatment of B cell malignancies including relapsed or refractory non-Hodgkin lymphoma, relapsed or refractory chronic lymphocytic leukemia ...

From the deaths of John Sykes and former Planned Parenthood President Cecile Richards to an update from Mike Peters, here’s ...

The two main types of acute leukemia are acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). Each can cause symptoms over days or weeks, including: Chronic leukemia causes problems in ...

TBI remained significantly associated with reduced adjusted risks of grade 3 to 4 aGVHD and moderate-severe cGVHD.

Panelists discuss how challenges in implementing emerging Bruton tyrosine kinase inhibitor (BTKi) regimens for ...

In an interview, Paolo Ghia, MD, PhD, discussed updated data from the phase 2 CAPTIVATE trial of ibrutinib and venetoclax in ...

Chronic Lymphocytic Inflammation with Pontine Perivascular ... and the role of specific immune cells in mediating inflammation[3]. Understanding these underlying mechanisms is essential for ...

Chemotherapeutic agents are often used to treat cancer. They combat tumor growth, but also have a number of undesirable side ...

The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...